EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring
Key result
Home Monitoring facilitated follow-up for ICD patients resulted in similar total follow-up-related costs for providers compared to regular in-office follow-up (€204 vs. €213; P=NS).
Why the study?
Does Home Monitoring facilitated follow-up reduce total follow-up-related costs for providers in patients with ICD implants?
Population
312 patients with VVI- or DDD-ICD implants, average age 62.4, 81% male, from 17 centres in six EU countries.
Comparison
Home Monitoring facilitated follow-up during the… vs Regular in-office follow-up during the first 2…
Design
RCT, randomised to HM ON or OFF
Follow-up
2 years
Authors
Discussion
Loading...
Member takes
Implication
Remote ICD follow-up costs comparable for providers; leaves open optimal reimbursement and implementation strategies.
Study Design
Type
RCT (n=312)
Randomization
randomized
Multicenter
Yes
Structured PICO
Does Home Monitoring facilitated follow-up reduce total follow-up-related costs for providers in patients with ICD implants?
P
Population
312 patients with VVI- or DDD-ICD implants from 6 European countries, followed for 2 years to evaluate the financial impact of remote monitoring.
I
Intervention
Home Monitoring facilitated follow-up (HM ON) during the first 2 years after ICD implantation
C
Comparator
Regular in-office follow-up (HM OFF) during the first 2 years after ICD implantation
O
Outcome
Total follow-up-related cost for providers during the first 2 years after ICD implantation
Main Result
Absolute Event Rate: 204% vs 213%
p-value: p=NS
Remote follow-up of ICD patients reorganizes care but does not significantly change total follow-up-related costs for providers compared to in-office follow-up, though financial impact varies by country-specific reimbursement.
Limitations
- Monetary valuation analysis was not performed for Finland due to low enrollment (n=2).
Cite This Study
Heidbüchel et al. (2014) conducted an RCT in Implantable cardiac defibrillators (ICDs) (n=312). Home Monitoring facilitated follow-up (HM ON) vs. Regular in-office follow-up (HM OFF) was evaluated on Total follow-up-related cost for providers (95% CI -36 to 54, p=NS). Home Monitoring facilitated follow-up for ICD patients resulted in similar total follow-up-related costs for providers compared to regular in-office follow-up (€204 vs. €213; P=NS).